Sugarbaker PH. New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome? Lancet Oncol. 2006;7:69–76.

Article  Google Scholar 

Ahmadi N, Kostadinov D, Sakata S, Ball WR, Gandhi J, Carr NJ, et al. Managing recurrent pseudomyxoma peritonei in 430 patients after complete cytoreduction and HIPEC: a dilemma for patients and surgeons. Ann Surg Oncol. 2021;28:7809–20.

Article  Google Scholar 

Baratti D, Milito P, Kusamura S, Martin Roman L, Guaglio M, Deraco M. Systemic metastases from low-grade and high-grade pseudomyxoma peritonei: Treatments and outcomes. Eur J Surg Oncol. 2022;48:1590–7.

Article  Google Scholar 

Baratti D, Kusamura S, Guaglio M, Milione M, Pietrantonio F, Cavalleri T, et al. Relapse of pseudomyxoma peritonei after cytoreductive surgery and HIPEC. Pattern of failure, clinical management and outcomes. Ann Surg Oncol. 2022. https://doi.org/10.1245/s10434-022-12367-6.

Article  Google Scholar 

Levine EA, Votanopoulos K, Qasem SA, Philip J, Cummins KA, Chou JW, et al. Prognostic molecular subtypes of low-grade cancer of the appendix. J Am Coll Surg. 2016;222:493–503.

Article  Google Scholar